X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs WOCKHARDT - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON WOCKHARDT BIOCON /
WOCKHARDT
 
P/E (TTM) x 40.9 -14.0 - View Chart
P/BV x 7.1 1.7 430.3% View Chart
Dividend Yield % 0.2 0.0 6,975.2%  

Financials

 BIOCON    WOCKHARDT
EQUITY SHARE DATA
    BIOCON
Mar-18
WOCKHARDT
Mar-18
BIOCON /
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs1,1881,012 117.4%   
Low Rs305532 57.4%   
Sales per share (Unadj.) Rs68.7355.9 19.3%  
Earnings per share (Unadj.) Rs7.6-60.3 -12.5%  
Cash flow per share (Unadj.) Rs14.0-46.8 -29.9%  
Dividends per share (Unadj.) Rs1.000.01 10,000.0%  
Dividend yield (eoy) %0.10 10,338.2%  
Book value per share (Unadj.) Rs86.3257.8 33.5%  
Shares outstanding (eoy) m600.00110.63 542.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.92.2 500.9%   
Avg P/E ratio x98.9-12.8 -772.1%  
P/CF ratio (eoy) x53.4-16.5 -323.8%  
Price / Book Value ratio x8.63.0 288.8%  
Dividend payout %13.20 -79,820.1%   
Avg Mkt Cap Rs m447,90085,379 524.6%   
No. of employees `0006.16.3 98.3%   
Total wages/salary Rs m9,3119,371 99.4%   
Avg. sales/employee Rs Th6,705.86,295.0 106.5%   
Avg. wages/employee Rs Th1,514.21,498.3 101.1%   
Avg. net profit/employee Rs Th736.9-1,066.3 -69.1%   
INCOME DATA
Net Sales Rs m41,23439,369 104.7%  
Other income Rs m2,0621,202 171.5%   
Total revenues Rs m43,29640,571 106.7%   
Gross profit Rs m8,29118 45,306.0%  
Depreciation Rs m3,8511,495 257.5%   
Interest Rs m6152,555 24.1%   
Profit before tax Rs m5,887-2,830 -208.1%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m1,569257 610.5%   
Profit after tax Rs m4,531-6,669 -67.9%  
Gross profit margin %20.10 43,256.8%  
Effective tax rate %26.7-9.1 -293.4%   
Net profit margin %11.0-16.9 -64.9%  
BALANCE SHEET DATA
Current assets Rs m41,48633,796 122.8%   
Current liabilities Rs m21,41326,917 79.6%   
Net working cap to sales %48.717.5 278.6%  
Current ratio x1.91.3 154.3%  
Inventory Days Days6479 80.6%  
Debtors Days Days9489 105.5%  
Net fixed assets Rs m50,66139,664 127.7%   
Share capital Rs m3,000553 542.3%   
"Free" reserves Rs m48,80827,968 174.5%   
Net worth Rs m51,80828,522 181.6%   
Long term debt Rs m17,89821,731 82.4%   
Total assets Rs m99,89781,620 122.4%  
Interest coverage x10.6-0.1 -9,833.0%   
Debt to equity ratio x0.30.8 45.3%  
Sales to assets ratio x0.40.5 85.6%   
Return on assets %5.2-5.0 -102.2%  
Return on equity %8.7-23.4 -37.4%  
Return on capital %9.6-7.7 -125.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,0589,807 123.0%   
Fx outflow Rs m7,3481,789 410.8%   
Net fx Rs m4,7108,019 58.7%   
CASH FLOW
From Operations Rs m6,621684 967.4%  
From Investments Rs m-6,8406,302 -108.5%  
From Financial Activity Rs m-2,397-7,695 31.2%  
Net Cashflow Rs m-2,612-664 393.4%  

Share Holding

Indian Promoters % 40.4 74.5 54.2%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 2.3 365.2%  
FIIs % 10.7 7.7 139.0%  
ADR/GDR % 0.0 0.1 -  
Free float % 19.9 15.4 129.2%  
Shareholders   109,995 67,757 162.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   PLETHICO PHARMA  DIVIS LABORATORIES  ALEMBIC LTD  ALKEM LABORATORIES  ELDER PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 490 Points Higher; Oil & Gas and Telecom Stocks Witness Buying(Closing)

Indian share markets continued to witness buying interest and ended their trading session on a positive note. Gains were largely seen in the oil & gas sector.

Related Views on News

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 24, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS